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The effect of Euphorbia szovitsii Fisch. & C.A.Mey extract on the viability and the proliferation 
of MDA-MB-231cell line 
ABSTRACT 
Some medicinal herbs and compounds are known to target cancer cells, but the success of 
them as anticancer compounds depends to a large extent on their ability to activate pathways 
that kill cancer cells by arresting cell cycle and inducing apoptosis. The aim of this study was 
to determine the anticancer effects of Euphorbia szovitsii Fisch. & C.A.Mey. on the breast cancer 
cells to reveal the underlying mechanism of its anti-breast cancer properties. In this 
experimental study, triple negative breast cancer cell line (MDA-MB-231) was cultivated in 
RPMI 1640 medium. Hydroalcoholic extract (70:30) of aerial parts of the plant was prepared. 
The cultured cells were treated with different concentrations (0-1000 μg/ml) of E. szovitsii 
extract for 24 and 48 hours. Toxicity of the extract on MDA-MB-231 cells was examined 
using MTT (3-[4,5-dimethyl-2-thiazolyl]-2, 5 diphenyl tetrazolium bromide) test. The 
Annexin V–FITC Apoptosis Detection Kit was used to evaluate apoptosis and necrosis. Flow 
cytometry technique was employed to differentiate different phases of the cell cycle in the 
cells. Data were analyzed by GraphPad Prism and SPSS software. After 24 and 48h, the IC50 
values were respectively 76.78 (95% CI=60.75 to 97.05; R=0.8588) and 59.71 (95% 
CI=46.25 to 77.09; R=0.8543) μg/ml for E. szovitsii,. The extract exhibited antiproliferative 
effects against MDA-MB-231 cells in a dose-dependent manner. Annexin V-FITC/PI assay 
confirmed that the extract was able to induce apoptosis in MDA-MB-231 cells. Moreover, 
treatment with the extract resulted in cell cycle arrest at G1 phase. Therefore, E. szovitsii could 
induce apoptosis and arrest cycle arrest in the MDA-MB-231 cell line. It might be a good 
resource of natural products for producing anti-breast cancer drugs.  
Keywords: Medicinal plants, Toxicity, Apoptosis, Cell cycle analysis; Drug discovery. 
Introduction 
Breast cancer is the most common cancer in women around the world. It is the leading cause 
of cancer death in less developed countries. According to the global cancer project (2012), 
nearly 1.7 million new cases of breast cancer have been diagnosed (12% of all new cancer 
cases) and 521,907 cases of deaths due to breast cancer occurred in the world [1; 2]. 
Despite the many drugs used to treat breast cancer, the incidence and prevalence of this 
cancer is still high. Besides that, many of the chemical drugs used to treat breast cancer lead 
to several side effects that limit their use for patients. Meanwhile, the production of drugs 
with higher efficacy and fewer side effects has always been taken into account. Medicinal 
plants are one of the most important natural resources of the options offered by researchers 
and pharmacists and, if they are used at certain doses, they will show the highest 
compatibility with the immune system. Medicinal plants, in many cases, have antioxidant and 
anti-inflammatory properties that can reduce the side effects of chemical drugs [3; 4]. In 
previous studies on the anticancer effects of medicinal plants in Chaharmahal and Bakhtiari 
province, a plant from the Euphorbia family, namely, E. szovitsii Fisch. & C.A.Mey., was 
among the plants that exhibited anticancer effects on various cancers such as breast cancer. In 
addition, in examining cells under treatment, significant morphological changes were 
observed, including major changes in the normal state of cell membrane and cell granulation, 
shrinkage of the membrane of the nucleus, and decrease in the cell volume. In addition, a 
number of cells have been isolated from the flask floor and floated. 
In this paper, we have evaluated the anticancer effects from E. szovitsii on the MDA-MB-231 
cells to determine the underlying mechanism of its anticancer effects. 
 
Experimental  
Cell culture 
Triple negative breast cancer cell line (MDA-MB-231 cells) was purchased from Pasteur 
Institute, Iran-Tehran. The cells were grown in RPMI 1640 medium at 37°C in a humidified 
atmosphere with 5% CO2- 95% air. The medium was refreshed every 24 hours, and the cells 
were trypsinized (0.1% trypsin) on reaching 80% confluency.  
 
Preparation of the herbal extract  
E. szovitsii was collected from Saman in Chaharmahal and Bakhtiyari province and air dried 
in the shade at RT (25 0C). The plant was authenticated by Dr. Shirmardi (Research Center 
for Agricultural & Natural Resources, Shahrekord, Iran). A voucher specimen was prepared 
and deposited in Herbarium unit of Shahrekord University of Medical Sciences (Skums-935). 
The aerial parts were ground by a mechanical grinder. The hydroalcoholic extract 
(Alcohol:water=70:30) of the plant was provided using maceration method at room 
temperature. The extract was then filtered through Whatman paper no.40 and the resultant 
filtrate was evaporated under negative pressure using a rotary vacuum evaporator.  
 
Cell viability assay 
For evaluating the cell viability, MDA-MB231 cells were exposed to a wide concentration 
range of the E. szovitsii extract (0-1000 µg/ml). Toxicity of the extract on breast cancer cells 
was examined using MTT (3-[4,5-dimethyl-2-thiazolyl]-2, 5 diphenyl tetrazolium bromide) 
assay 24 and 48 hours after seeding.  
Briefly, 7*10
3
 cells were seeded into each well of a 96-well plate. After 24 hours, the 
attached cells were treated with different concentrations (0-1000 μg/ml) of E. szovitsii extract  
in two time intervals (24 and 48 hours). The negative control was not treated with any 
concentration of E. szovitsii extract. After incubation, supernatant was discarded and the 
attached cells rinsed with PBS. Then, 100 MTT solution (2 mg/ml PBS) was added to each 
well and incubated 4 h at 37
0
C. Eventually, supernatant of each well was removed again, 
mixed with 200 μl DMSO and gently shacked for a while to subsequently keep in dark place.  
The cell viability of the treated cells was measured at 570 nm by Stat-Fax 2100 microplate 
reader (Awareness Technology Inc) and the calculated according to the following equation:  
Percentage of Viability=proportion of sample absorbance/control absorbance. 
 
Apoptosis analysis 
In other to apoptosis assay the flow cytometry technique was used. MDA-MB231 cells were 
seeded in 6-well plates at a density of approximately 120*10
3
 cells. 24 hours after seeding, 
the cells were exposed with IC50 values of E. szovitsii extract. The treated cells were 
harvested after 24 and 48 hours, rinsed twice with cold PBS. The pellet (at a concentration of 
10
6
 cells/ml) resuspended in 500 μl Binding Buffer (1X), and incubated with 5 μl FITC-
Annexin V and 5 μl PI. The samples were gently vortexed and incubated for 15 min at Rome 
temperature in the dark. 400 µl of 1X Binding Buffer was added to each tube [5].  One hour 
after incubation, flow cytometric technique was performed by a flow cytometer 
(CyFlow, Partec, Munster, Germany). The results were analyzed using FCS Express 5 reader 
(De Novo Software). 
 
Cell cycle assay 
For calulation the content of DNA in various phases of cell cycle, the cells were seeded into 
6-well plate and treated with IC50 values of E. szovitsii extract 24 h after seeding. Cell cycle 
assay was conducted according to the standard protocol 24 and 48 h after treatment. Briefly, 
5*10
5
 treated cells were incubated with 250 μL of trypsin buffer (as Solution A) and 200 μL 
of trypsin inhibitor with RNase buffer (as Solution B) at 20°C– 25°C for 10 min, 
respectively. Then, 200 μL of cold PI stain solution (as Solution C) was added and incubated 
in the dark for 10 min on ice [6]. Finally, the samples were read via a flow cytometer 
(CyFlow, Partec, Munster, Germany) and data were analyzed through FCS Express 5 reader 
(De Novo Software). 
 
Statistical analysis 
The IC50 values were determined using GraphPad Prism 6.0 software through regression 
analysis. ANOVA (One-way analysis of variance) was used to compare the data. P<0.05 
considered significant. 
 
Results 
E. szovitsii extract indicated cytotoxic effects on MDA-MB231 cells obviously. The extract 
exhibited cytotoxic effects on breast cancer cell line in a dose-dependent manner (Figure 1). 
The IC50 values were gained 76.78 (95% CI=60.75 to 97.05; R=0.8588) and 59.71 (95% 
CI=46.25 to 77.09; R=0.8543) μg/ml 24 and 48h after treatment, respectively (Figure 2). 
 
 
Figure 1: Microscopic photos of triple negative breast cancer cell line (MDA-MB231) 
treated with the Euphorbia szovitsii Fisch. & C.A.Mey. extract 
A: Control cells (None treated cells); B: Treated by 50 µg/ml of E. szovitsii after 24 h; C: Treated 
by 50 µg/ml of E. szovitsii after 48 h; D: Treated by 100 µg/ml of E. szovitsii after 24 h; E: Treated 
by 100 µg/ml of E. szovitsii after 48 h. 
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Figure 2: Cell viability evaluation of triple negative breast cancer cell line (MDA-MB231) 
treated with the Euphorbia szovitsii Fisch. & C.A.Mey. hydroalcoholic extract 
E. szovitsii induced apoptosis in breast cancer cell line 
In order to apoptosis evaluation, MDA-MB231 cells were treated with 50 (as minimum 
concentration of IC50 value) and 100 µg/ml (as maximum concentration of IC50 value) of E. 
szovitsii extract. Flow cytometry technique via FITC Annexin V Apoptosis Detection Kit II 
was used to determine necrotic and apoptotic cells. In this method, Annexin V-FITC positive 
and PI negative cells were considered as early apoptotic cells (Q4); Annexin V-FITC positive 
and PI positive cells were considered as late apoptotic cells (Q2); and Annexin V-FITC 
negative and PI positive cells were considered as necrotic cells (Q1) (Figure 3).  
Sum of early apoptotic cells and late apoptotic cells were calculated as the rate of apoptosis. 
The results indicated an increase in apoptotic cells in 24 and 48 h after treatment via IC50 
values of the E. szovitsii extract (Figures 4). 
 
 
 
  
Figure 3: Euphorbia szovitsii Fisch. & C.A.Mey. hydroalcoholic extract induces apoptosis in 
the MDA-MB231 cells 
A: Control cells (None treated cells) after 24 h; B: Treated by 50 µg/ml of E. szovitsii after 24 h; 
C: Treated by 100 µg/ml of E. szovitsii after 24 h; D: Control cells (None treated cells) after 48 h; 
E: Treated by 50 µg/ml of E. szovitsii after 48 h; F: Treated by 100 µg/ml of E. szovitsii after 48 h. 
Q4: early apoptotic cells (Annexin V-FITC positive, PI negative); Q2: late apoptotic cells 
(Annexin V-FITC positive, PI positive); Q1: necrotic cells (Annexin V-FITC negative, PI 
positive). 
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 Figure 4: The rate of apoptosis in treated MDA-MB231 cells with Euphorbia szovitsii 
Fisch. & C.A.Mey. hydroalcoholic extract 
C: Control; E50: E. szovitsii with 50 µg/ml concentration; E100: E. szovitsii with 100 µg/ml 
concentration. 
 
E. szovitsii arrested cell cycle in breast cancer cell line 
DNA content was analyzed in different phases of the cell cycle and percentage of the cells in 
any phases was compared with the control groups (Figure 5). Treatment of breast cancer cell 
line with E. szovitsii extract caused an increase of the percentage of the cells at the G1 phase; 
whereas a decrease was seen in the cell population at the S phase. G2 phase indicated a 
decrease until 48 h, but after 48 h it indicated an increase in proportion compared with the 
control cells. The cells treated with 50 and 100 µg/ml of E. szovitsii after 48 h showed a 
decrease in proportion of the cells in G2/M. (Table 1). Percentage of the cells in different 
phases of the cell cycle in treated cells was significantly different from them in the control 
group (P<0.05). 
Table 1: Percentage of the MDA-MB231 cells treated with Euphorbia szovitsii Fisch. & 
C.A.Mey. hydroalcoholic extract in different phases of the cell cycle  
E50: E. szovitsii with 50 µg/ml concentration; E100: E. szovitsii with 100 µg/ml concentration. 
 
    
 
 
Groups G1 (%) S (%) G2 (%) G2/G1 
24 h 
Control 43.23 39.06 17.71 1.92 
E50 58.25 30.01 11.74 1.91 
E100 62.09 22.78 15.14 1.93 
48 h 
Control 54.35 36.32 9.33 1.98 
E50 67.58 18.89 13.54 1.92 
E100 69.18 13.38 17.44 1.89 
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Figure 5: Euphorbia szovitsii Fisch. & C.A.Mey. hydroalcoholic extract arreste cell cycle in 
the MDA-MB231 cells 
A: Control cells (None treated cells) after 24 h; B: Treated by 50 µg/ml of E. szovitsii after 24 h; 
C: Treated by 100 µg/ml of E. szovitsii after 24 h; D: Control cells (None treated cells) after 48 h; 
E: Treated by 50 µg/ml of E. szovitsii after 48 h; F: Treated by 100 µg/ml of E. szovitsii after 48 h. 
 
Discussion  
In present study that designed to evaluate the anticancer effects of E. szovitsii on the MDA-
MB-231 cells and to determine the underlying mechanism of its anticancer effects, the 
studied plant could induce apoptosis and arrest cell cycle in the breast cancer cell line. 
Today, one of the interesting strategies that has been considered in cancer chemotherapy is 
drug interventions that can mediate the death of malignant cells by inducing apoptosis. In the 
present study, the extract of E. szovitsii, at both higher- and lower-than-IC50 concentrations, 
was able to kill the cancer cells by inducing apoptosis. The plant was able to exhibit its 
apoptotic effect even after 24 hours, and there was no significant difference in apoptosis 
between 24 and 48 hours after treatment. So far, many medicinal plants and compounds have 
been observed to show anticancer effects by inducing apoptosis. Although many plants are 
able to induce apoptosis, in some studies, the extracts have been observed to induce death 
through the necrosis pathway, which limits their use to some extent. In addition, most of the 
plants evaluated in the previous studies have shown greater apoptotic effects after 48 hours 
[7-11]. Based on the results of this study and previous studies, this plant may be considered 
as one of the potential anticancer plants due to its anti-apoptotic effects after 24 hours, as well 
as the low rate of necrosis induction. 
In cancer cells, the regulation of the cell cycle control points was disturbed, resulting in a 
decrease in the percentage of cells, in particular the cells present in the G1/G0 phase, and the 
percentage of the cells present in the S phase [12]. In our study, the anticancer effect of the 
extract on cell cycle phases may suggest that the extract at both lower- and higher-than-IC50 
levels can arrest the cell cycle in the G1 phase and also decrease the amount of cells in the S 
phase. In the study of Choene et al (2016), the growth inhibiting effects of the E. turicalli 
extract on different breast cell lines including MDA-MB 231 and MCF-7 were investigated. 
The plant extract exhibited growth inhibiting effects in cell type- and concentration-
dependent manner after 48 hours and arrested the cell cycle in the G0/G1 phase due to 
excessive expression of p21 [13]. Studies have shown plants that are selectively able to arrest 
the cell cycle in a particular phase can be a good choice for anticancer therapies, and 
compounds that arrest the cell cycle during the G1/S transitional phase are typically 
nucleotide synthesis inhibitors [14]. These results indicate that the plant extract, as a 
nucleotide synthesis inhibitor, can be a good choice to develop anticancer drugs especially to 
treat breast cancer. In the study of Choene and Motadi (2016), various types of secondary 
metabolites including flavonoids and terpenes in E. tirucalli were reported, and the anticancer 
effects of this plant was attributed to these compounds [13]. 
In Iran, Zare et al. (2016) investigated the chemical composition of another species of the 
Euphorbia genus, namely, E. macrostegia, and observed that the plant had a wide range of 
active compounds, including tertipanes and unsaturated fatty acids, that can have anticancer 
effects [15]. Specifically, the anticancer effects of other compounds such as jolkinolide B, 
euphoscopin, euphohelioscopin, euphornin A, helioscopinolide, steroids and triterpenes 
obtained from different species of the Euphorbia genus have been studied on various breast 
cancer cells and their positive effects have been confirmed [16-19]. The results of this study 
and previous studies indicate that the species of the Euphorbia genus may be able to exert 
anticancer effects due to the presence of terpenoid 
i
compounds. 
 
Conclusion  
E. szovitsii indicated anti-breast cancer effects with visible morphological changes on the 
MDA-MB231 cell line. The extract could induce apoptosis and cell cycle arrest in the MDA-
MB-231 cell line. We believe that E. szovitsii extract can be considered as a proper candidate 
for cancer therapy. It should be evaluated in in vivo studies and human clinical trials for 
producing an anti-breast cancer drug. 
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